Clinical Trial Update: Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the combination of bevacizumab and sorafenib in patients with recurrent glioblastoma multiforme; the study is completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Bevacizumab (bevacizumab)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED | Results posted: 2017-01-04